Violation Tracker Individual Record
: Aventis Pharmaceuticals Inc.
Current Parent Company
Parent at the Time of the Penalty AnnouncementPenalty
to see this data field
: September 10, 2007
: government-contracting-related offenses
: False Claims Act and related
: Aventis Pharmaceuticals Inc. paid the United States and a number of states, as well as the District of Columbia, over $190 million to resolve allegations that the company caused false claims to be filed with Medicare and other federal health programs as a result of the company's alleged fraudulent pricing and marketing of drugs. Aventis, which changed its name to Sanofi-Aventis, agreed to settle False Claims Act allegations concerning its pricing and marketing of Anzemet, an antiemetic drug used primarily in conjunction with oncology and radiation treatment to prevent nausea and vomiting.
Level of Government
: agency action
: Justice Department Civil Division
Civil or Criminal Case
HQ Country of Current Parent
Ownership Structure of Current Parent
: publicly traded
Major Industry of Current Parent
Specific Industry of Current Parent
Source of Data
: (click here)
: If an online information source is not working, check the Violation Tracker Data Sources page
for an updated link.
Current parent company note
: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log